We saw significant transcriptional changes including the downregulation of key markers like EGR1 and CD24, whose reduced expression is linked to increased invasiveness and drug resistance and identified proteins such as TRIP6 and TRIM29 that enhance (cancer stem cells) CSC-like properties [40, 41]. The gene discussed is TRIP6; the disease is cancer.